Clinical Trial Update: PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm) [Phase 2]

View source ↗

Summary

This Phase 2, five-arm PK/PD and steady-state efficacy trial evaluated bilastine versus placebo in seasonal allergic rhinitis with rhinoconjunctivitis symptoms …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinoconjunctivitis
• Hay Fever
• Seasonal Allergic Rhinitis

Drugs mentioned

• Bilastine (bilastine)

Snippet

Sponsor: Faes Farma, S.A. | Conditions: Seasonal Allergic Rhinitis, Hay Fever | Phase 2 | Status: COMPLETED